Neovasc Inc. is a medical device company that specializes in developing and manufacturing products for cardiovascular markets worldwide. The company offers the innovative Tiara technology for transcatheter treatment of mitral valve disease and Neovasc Reducer for the treatment of refractory angina. Formerly known as Medical Ventures Corp., the company was incorporated in 2000 and is based in Richmond, Canada.